Skip to content

Laxmi Organic Industries Limited (LXCHEM)

Micro Cap

Chemicals stocks · Micro cap · NSE

Laxmi Organic Industries Limited manufactures specialty chemicals and intermediates, including diketene derivatives and acetyl intermediates, servicing pharma, agro, pigments, coatings, and packaging industries globally.

₹161
-10.14 · -5.92%
Market cap ₹4,474 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 05:57 pm IST
Details
Quote21 Oct, 05:57 pm IST
Base fundamentals22 Oct 2026 · screener
Latest result30 Jul, 02:19 am IST
Score22 Oct, 05:17 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 33.5 (n=46)
Technical timing lens

Trend score and candlestick chart

50Neutral

SMA20 +3.9% / mo · MACD − · sector -5.7pp vs Nifty 500 (3M)

Stock trend: 58
Sector RS: 39
Sector 3M: -11.3% vs Nifty 500 -5.6%

Latest FPI flow is positive, but a second consecutive positive fortnight is still required. View sector evidence

Technical chart

LXCHEMD candles · FIT view+8.2%
Latest close ₹161.00 on 2026-10-21
Bar
-6.0%
RSI
39
MACD hist
-2.11
52W pos
53%
Visible chart range
Candle interval
2026-10-21O ₹171.20H ₹172.66L ₹159.47C ₹161.00Vol 17.7L sh
₹130.31₹149.56₹168.81₹188.05₹207.30₹161.002026-032026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

LXCHEMNifty ChemicalsNifty 500
-14%-5%+4%+13%21 Jul2 Sept21 Oct21 Oct 2026LXCHEM -11.3%Nifty Chemicals -12.2%Nifty 500 -6.5%
LXCHEM
-11.3%
Nifty 500
-6.5%
Nifty Chemicals
-12.2%
Vs Nifty 500
-4.8 pp
Chart stats
21 Oct 2026
From 52W high
-23.0%
₹209
52W range position
53%
₹107.6 - ₹209
ATR (14)
5.5%
₹8.9
Volume vs 20D
1.22x
Latest completed session
Avg traded value
₹27.6 Cr
20-session average
20D price channel
₹159.5 - ₹193.8
59.6% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED
27

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Excellent
100

Revenue +39.7% · PAT +223.8% YoY

Technical
Neutral
50

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-777.7%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
63

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Excellent · 100/100

Rev +40% YoY · PAT +224% YoY · margin expansion · +32% QoQ · operating leverage

Filed 29 Jul 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹968 Cr+39.7%+31.7%
EBITDA₹114 Cr+267.7%+111.1%
Operating margin12.0%+760 bps+500 bps
PAT₹68 Cr+223.8%+209.1%
PAT margin7.0%+399 bps+403 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
35.60
P/B
2.25
EV/EBITDA
14.93
Market Cap
4474.00Cr

Profitability

ROE
4.11%
ROCE
4.72%
ROA
3.66%
Dividend Y
0.17%

Growth (CAGR)

Revenue 5Y
10.00%
EPS 5Y
-9.00%
Revenue 3Y
1.00%
EPS 3Y
-14.00%

Balance Sheet

Debt/Equity
0.28
Interest Coverage
12.14×
Altman Z
3.85
Book Value
71.60

Cash Flow

FCF Yield
—
FCF Positive Y
6/5
OCF
175.00 Cr
EPS TTM
4.54

Shareholding

Promoter Hold
69.16%
Promoter Pledge
0.00%
Momentum 52W
53%

Financial History

Updated 22/10/2026

Revenue

₹ Cr
Latest: 2,847-4.6% vs prev
03084Mar 2017: 1,076Mar 2018: 1,376Mar 2019: 1,569Mar 2020: 1,534Mar 2021: 1,768Mar 2022: 3,084Mar 2023: 2,797Mar 2024: 2,865Mar 2025: 2,985Mar 2026: 2,847FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Net Profit

₹ Cr
Latest: 79.0-30.7% vs prev
0256.0Mar 2017: 72.0Mar 2018: 76.0Mar 2019: 72.0Mar 2020: 70.0Mar 2021: 127Mar 2022: 256Mar 2023: 125Mar 2024: 121Mar 2025: 114Mar 2026: 79.0FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Return on Equity

%
Latest: 144+2302.0% vs prev
0143.6Mar 2017: 23.6%Mar 2018: 20.1%Mar 2019: 16.0%Mar 2020: 16.4%Mar 2021: 12.3%Mar 2022: 19.7%Mar 2023: 8.8%Mar 2024: 6.7%Mar 2025: 6.0%Mar 2026: 144%FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term uptrend intact. RSI 39. Wait for confirmation.

  • Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
  • SMA20 rising (~3.7% over last month) — short-term momentum positive.
  • RSI(14) at 39 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 23% off 52W high · 50% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

53
RS percentile
Stage 1 Base / Transition
1M return
-9.4%
3M return
-11.3%
6M return
+12.8%
1Y return
-20.8%
RS 1D
-8
RS 20D
-11
Sector rank
#14
Industry rank
#45
Stage evidence
  • Price is within 0.4% of the 30-week proxy.
  • The 30-week proxy changed +5.1% over 20 sessions.
  • The moving-average structure does not confirm Stage 2 or Stage 4.
50-DMA
price below
200-DMA
price above
Sector
weakening
Industry
weakening
Relative-strength line vs Nifty 500 (base 100)
262 observations
21 Oct 2026Value 81.51-5.04%
54678093106Sept 25Feb 26Jun 26Oct 2682
RS vs Nifty 50082

Valuation & peers

U-Score 27 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

27U-SCORE
OVERVALUED

Fundamental score breakdown

U band · OVERVALUED
Valuation3/30
Growth4/25
Quality0/20
Balance Sheet11/15
Cash Flow4/10
Piotroski
7/9 (+5)
Penalties
0
Raw sum
27

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

27/100 · legacy band OVERVALUED

Positive drivers

  • Piotroski is strong at 7/9.
  • Balance sheet contributes 11/15 to the score.
  • Cash flow contributes 4/10 to the score.

Main drags

  • Fair-value margin of safety is negative at -777.7%.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Valuation is weaker at 3/30; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
35.6
PB
2.3
EV/EBITDA
14.9
ROE
4.1%
ROCE
4.7%
FCF Yield
—
Debt/Equity
0.3
MoS
-777.7%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 22 Oct 2026
v4.3-runtime-valuation
Final score
27
Previous: 27
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-777.7%
Previous: -777.7%

Score history

12 stored score snapshots. Latest stored move: +2 points.

22 Oct 2026
v4.3-runtime-valuation
25
25
25
25
25
25
25
25
25
25
25
27

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹85.52
-88.3% MoS
Growth-justified P/E
4.0
Growth-justified Value
₹18.34
-777.7% MoS
PEG
—

Comparable companies

Peers

Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
REFEX
Micro
Refex Industries Limited
Retail
match 104
73
11.5
17.8%
+71%
UNDERVALUED
RAIN
Micro
Rain Industries Limited
Retail
match 102
40
14.3
0.6%
-1080%
WATCHLIST
PRAJIND
Micro
Praj Industries Limited
Retail
match 95
26
96.4
1.5%
-7860%
OVERVALUED
RENUKA
Micro
Shree Renuka Sugars Limited
Retail
match 94
14
—
—
—
OVERVALUED
TRIVENI
Micro
Triveni Engineering & Industries Limited
Retail
match 94
31
19.8
8.7%
-188%
OVERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-10-22T10:40:15.056Z
Management commentary snapshot

Q1 FY27 revenue grew 40% YoY and 32% QoQ to INR9,683 million, driven by a 10% volume growth, higher price realizations, and procurement efficiencies amidst raw material volatility.

The investment thesis remains intact. Scale benefits, end-to-end integration, and robust demand drove strong Q1 performance. Essentials EBITDA improved significantly, and the Dahej specialty project is nearing completion for a Q4 ramp-up.

Current business mix

Revenue by business vertical

Latest issuer-disclosed distribution across 2 reported categories.

Businessmix
Essentials Business75.0%
Specialty Business25.0%
Growth engines

Dahej Project Expansion

POSITIVE

Dahej Phase 2 capex is nearing completion, doubling diketene derivatives capability with commercialization and customer qualification targeted for Q3/Q4.

Electrochemical Fluorination Platform

POSITIVE

Company holds first-mover advantage in India with a robust new product development pipeline leveraging electrochemical fluorination technology.

Scale and Integration in Essentials

POSITIVE

Global economies of scale and end-to-end integration enable the company to capture upcycle benefits and secure customer requirements.

Capacity and execution

Dahej Project Phase 2

ON_TRACK

85% of Phase 2 capex will be capitalized in Q2, with mechanical completion in Q3, customer qualification in Q3, and ramp-up in Q4.

World-scale Ethyl Acetate Capacity

COMPLETED

World-scale ethyl acetate capacity at the Lote site was successfully commissioned and is currently being deployed into the market.

Tailwinds

Global Capacity Restructuring

POSITIVE

Ongoing capacity restructuring, realignments, and shutdowns in Europe, Japan, and Korea benefit large players with economies of scale.

Positive Industrial Demand Momentum

POSITIVE

Positive demand momentum observed in industrial solutions, coatings, and newer-age industries serviced by the company.

Headwinds

Logistics and Feedstock Disruptions

CAUTION

Geopolitical uncertainties, West Asia crises, Red Sea bottlenecks, and a South China typhoon created logistics disruptions and feedstock price spikes.

Customer Site Softness

CAUTION

Downstream pigment sites experienced certain softness, and feedstock volatility made buyers cautious with purchasing behavior.

Risk radar

Working Capital Inflation

MONITOR

Net working capital increased during the quarter due to strategic inventory procurement to secure raw material availability amidst volatility.

Essentials Margin Cyclicality

MONITOR

Essentials segment margins are subject to wide cyclical swings depending on daily and weekly raw material spread settlements.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare BOTH

Year-over-year comparison captures cyclical recovery and price realization trends, while quarter-on-quarter comparison reflects sequential momentum, spread changes, and project execution milestones.

Sector KPIs management disclosed

Volume Growth

POSITIVE

Enterprise-level volume growth stood at around 10% for Q1 FY27, supported by double-digit volume growth in the Essentials segment.

Realizations & Spreads

POSITIVE

Ethyl acetate spreads in March and April were higher than the 12-year average range of $215-$220 per ton, driven by raw material price spikes.

Utilization & Capacity

POSITIVE

World-scale ethyl acetate capacity at Lote has been commissioned, and Dahej Phase 2 capex is nearing completion for upcoming commercialization.

Management forward view

Normalizing Working Capital

PLANNED

Management expects net working capital to normalize over time as volatile operating conditions stabilize.

Peak Debt Levels

ACHIEVED

Term debt has peaked at approximately INR6,100 million with the nearing completion of the Dahej capex cycle, maintaining a net debt-to-equity of 0.3x.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Dahej Phase 2 CommissioningMechanical completion expected in early Q3Customer qualification in Q3 and commercial ramp-up in Q4 FY27
Essentials Segment EBITDA MarginsDelivered 11% to 12% in Q1 FY27Sustainability over the cycle against historical mid single-digit averages
Net Debt and Working CapitalTerm debt peaked at INR6,100 million; net D/E at 0.3xWorking capital normalization and commencement of debt repayments next year

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Trust Score
63Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 38th percentile of the scored universe and 23rd percentile within Chemicals. Main check: financial discipline is weak at 30/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
90 docs text-extracted · 35 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
38th percentile

overall median 67 · Chemicals: 23rd pctile, median 73 · Micro: 21st pctile, median 73

Evidence depth
Financial-only

90 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
67
acceptable · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
30
weak · capital discipline
Results
34
weak · quarterly consistency

Trust positives

  • ▸Promoter holding is 69.3%.
  • ▸Promoter pledge is zero.
  • ▸6 years of positive FCF.

Trust risks

  • ▸ROCE is low at 4.7%.
  • ▸ROE is low at 4.1%.
  • ▸ROCE trend is -2.9%.
  • ▸1/4 latest quarters had positive YoY PAT growth.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

11 shown
Investor presentationAug 2026

Aug 2026 · PPT

Source: Bse

Open source ↗
Concall transcriptAug 2026

Aug 2026 · Transcript

Source: Bse

Open source ↗
Annual reportAug 2026

Aug 2026 · General Update Under Reg 36(1)(B) 14 Jul - 37th AGM scheduled for August 5, 2026; annual report 2025-26 web-link shared.

Source: Bse

Open source ↗
AnnouncementJul 2026

Jul 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 1d - Q1 FY27 earnings conference call scheduled for July 30, 2026 at 2:00 PM IST.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Jul - Laxmi Organic Industries has informed about copy of newspaper publication with respect to the Notice of 37th Annual General Meeting to be held on August …

Source: Bse

Open source ↗
AnnouncementJun 2026

Jun 2026 · Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Jul - Laxmi Organic Industries Limited has Submitted copy of Newspaper Publication of the Financial Results for the Quarter ended June 30, 2026.

Source: Bse

Open source ↗
Announcement

Announcement Under Regulation 30 Of SEBI (LODR), 2015 23 Jun - Laxmi Organic clarified no undisclosed material information behind trading volume movement.

Source: Bse

Open source ↗
Investor presentationMay 2026

May 2026 · PPT

Source: Bse

Open source ↗
AnnouncementQ4 2026

Q4 2026 · Compliances-Reg.24(A)-Annual Secretarial Compliance 27 May - FY26 secretarial compliance report filed; minor delays noted in two Regulation 30 disclosures and SDD updates.

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.